- directed: true
  graph:
    disease: Candidiasis, Vulvovaginal
    disease_mesh: MESH:D002181
    drug: clotrimazole
    drug_mesh: MESH:D003022
    drugbank: DB:DB00257
  links:
    - key: negatively regulates
      source: MESH:D003022
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D002181
  multigraph: true
  nodes:
    - id: MESH:D003022
      label: Drug
      name: clotrimazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D002181
      label: Disease
      name: Candidiasis, Vulvovaginal
  reference: https://go.drugbank.com/drugs/DB00257#BE0000233 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacodynamics https://en.wikipedia.org/wiki/Ergosterol#Target_for_antifungal_drugs
  comments: This drug is fungistatic at concetrations up to 20 mcg/mL, and is fungicidal in vitro when used at higher concentrations. Also please note that MESH:D002181 was initially denoted as Candidal vulvovaginitis in the original xls file but the name on the MESH website, which is Candidiasis, Vulvovaginal, is the one used here for our annotation.
- directed: true
  graph:
    disease: Diaper rash
    disease_mesh: MESH:D003963
    drug: clotrimazole
    drug_mesh: MESH:D003022
    drugbank: DB:DB00257
  links:
    - key: negatively regulates
      source: MESH:D003022
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D003963
  multigraph: true
  nodes:
    - id: MESH:D003022
      label: Drug
      name: clotrimazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D003963
      label: Disease
      name: Diaper rash
  reference: https://go.drugbank.com/drugs/DB00257#BE0000233 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacodynamics https://en.wikipedia.org/wiki/Ergosterol#Target_for_antifungal_drugs
  comments: Diaper rash can be caused by different factors, including fungus, when it's known as diaper candidiasis. If a fungal origin is identified, the treatment is based on antifungals (e.g. clotrimazole). Therefore the original cause must be determined first as the treatments vary (https://en.wikipedia.org/wiki/Irritant_diaper_dermatitis#Secondary_infections).
- directed: true
  graph:
    disease: Candidiasis, Cutaneous
    disease_mesh: MESH:D002179
    drug: clotrimazole
    drug_mesh: MESH:D003022
    drugbank: DB:DB00257
  links:
    - key: negatively regulates
      source: MESH:D003022
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D002179
  multigraph: true
  nodes:
    - id: MESH:D003022
      label: Drug
      name: clotrimazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D002179
      label: Disease
      name: Candidiasis, Cutaneous
  reference: https://go.drugbank.com/drugs/DB00257#BE0000233 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacodynamics https://en.wikipedia.org/wiki/Ergosterol#Target_for_antifungal_drugs
  comments: MESH:D002179 was initially denoted as Candidiasis of skin in the original xls file but the name on the MESH website, which is Candidiasis, Cutaneous, is the one used here for our annotation.
- directed: true
  graph:
    disease: Candidiasis, Oral
    disease_mesh: MESH:D002180
    drug: clotrimazole
    drug_mesh: MESH:D003022
    drugbank: DB:DB00257
  links:
    - key: negatively regulates
      source: MESH:D003022
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D002180
  multigraph: true
  nodes:
    - id: MESH:D003022
      label: Drug
      name: clotrimazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D002180
      label: Disease
      name: Candidiasis, Oral
  reference: https://go.drugbank.com/drugs/DB00257#BE0000233 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacodynamics https://en.wikipedia.org/wiki/Ergosterol#Target_for_antifungal_drugs
  comments: MESH:D002180 was initially denoted as Candidiasis of mouth in the original xls file but the name on the MESH website, which is Candidiasis, Oral, is the one used here for our annotation.
- directed: true
  graph:
    disease: Tinea pedis
    disease_mesh: MESH:D014008
    drug: clotrimazole
    drug_mesh: MESH:D003022
    drugbank: DB:DB00257
  links:
    - key: negatively regulates
      source: MESH:D003022
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D014008
  multigraph: true
  nodes:
    - id: MESH:D003022
      label: Drug
      name: clotrimazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D014008
      label: Disease
      name: Tinea pedis
  reference: https://go.drugbank.com/drugs/DB00257#BE0000233 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacodynamics https://en.wikipedia.org/wiki/Ergosterol#Target_for_antifungal_drugs
- directed: true
  graph:
    disease: Tinea Versicolor
    disease_mesh: MESH:D014010
    drug: clotrimazole
    drug_mesh: MESH:D003022
    drugbank: DB:DB00257
  links:
    - key: negatively regulates
      source: MESH:D003022
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D014010
  multigraph: true
  nodes:
    - id: MESH:D003022
      label: Drug
      name: clotrimazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D014010
      label: Disease
      name: Tinea Versicolor
  reference: https://go.drugbank.com/drugs/DB00257#BE0000233 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacodynamics https://en.wikipedia.org/wiki/Ergosterol#Target_for_antifungal_drugs
  comments: MESH:D014010 was initially denoted as Pityriasis versicolor in the original xls file but the name on the MESH website, Tinea Versicolor, is the one used here for our annotation.
- directed: true
  graph:
    disease: Malaria, Falciparum
    disease_mesh: MESH:D016778
    drug: Artesunate
    drug_mesh: MESH:D000077332
    drugbank: DB:DB09274
  links:
    - key: negatively regulates
      source: MESH:D000077332
      target: UniProt:P04926
    - key: decreases abundance of
      source: UniProt:P04926
      target: MESH:D006427
    - key: in taxon
      source: MESH:D006427
      target: NCBITaxon:5833
    - key: causes
      source: NCBITaxon:5833
      target: MESH:D016778
  multigraph: true
  nodes:
    - id: MESH:D000077332
      label: Drug
      name: Artesunate
      alt_ids:
        - MESH:C111789
    - id: UniProt:P04926
      label: Protein
      name: Malaria protein EXP-1
    - id: MESH:D006427
      label: ChemicalSubstance
      name: Hemin
      alt_ids:
        - MESH:D006418
    - id: NCBITaxon:5833
      label: OrganismTaxon
      name: Plasmodium falciparum
    - id: MESH:D016778
      label: Disease
      name: Malaria, Falciparum
  reference: https://go.drugbank.com/drugs/DB09274#mechanism-of-action https://pubchem.ncbi.nlm.nih.gov/compound/6917864#section=Pharmacology-and-Biochemistry
  comments: MESH:D016780 was initially denoted as Falciparum malaria in the original xls file but the name on the MESH website is Malaria, Falciparum, which is the name used here for our annotation. Also note that heme and hematin are related substances resulting from the parasite hemoglobin catabolism. Heme is bound to iron whereas hematin is the hydroxide counterpart of heme. Both are cytotoxic.
- directed: true
  graph:
    disease: Malaria, Vivax
    disease_mesh: MESH:D016780
    drug: Artesunate
    drug_mesh: MESH:D000077332
    drugbank: DB:DB09274
  links:
    - key: negatively regulates
      source: MESH:D000077332
      target: Pfam:PF06589
    - key: decreases abundance of
      source: Pfam:PF06589
      target: MESH:D006427
    - key: in taxon
      source: MESH:D006427
      target: NCBITaxon:5855
    - key: causes
      source: NCBITaxon:5855
      target: MESH:D016780
  multigraph: true
  nodes:
    - id: MESH:D000077332
      label: Drug
      name: Artesunate
      alt_ids:
      - MESH:C111789
    - id: Pfam:PF06589
      label: GeneFamily
      name: Circumsporozoite-related antigen (CRA)
    - id: MESH:D006427
      label: ChemicalSubstance
      name: Hemin
    - id: NCBITaxon:5855
      label: OrganismTaxon
      name: Plasmodium vivax
    - id: MESH:D016780
      label: Disease
      name: Malaria, Vivax
  reference: https://go.drugbank.com/drugs/DB09274#pharmacodynamics https://pubchem.ncbi.nlm.nih.gov/compound/6917864#section=Pharmacology-and-Biochemistry
  comments: MESH:D016780 was initially denoted as Vivax malaria in the original xls file but the name on the MESH website, Malaria, Vivax, is the one used here for our annotation. Also note that heme and hematin are related substances resulting from the parasite hemoglobin catabolism. Heme is bound to iron and hematin is the hydroxide counterpart of heme. Both are cytotoxic to the parasite.
- directed: true
  graph:
    disease: Chronic hepatitis C
    disease_mesh: MESH:D019698
    drug: ABT-267
    drug_mesh: MESH:C586094
    drugbank: DB:DB09296
  links:
    - key: negatively regulates
      source: MESH:C586094
      target: UniProt:Q5L478
    - key: molecularly interacts with
      source: UniProt:Q5L478
      target: MESH:C000618292
    - key: increases abundance of
      source: MESH:C000618292
      target: MESH:C037178
    - key: positively correlated with
      source: MESH:C037178
      target: MESH:D002784
    - key: located in
      source: MESH:D002784
      target: MESH:D000086969
    - key: location of
      source: MESH:D000086969
      target: GO:0039694
    - key: positively regulates
      source: UniProt:Q5L478
      target: GO:0003968
    - key: positively regulates
      source: GO:0003968
      target: GO:0039694
    - key: positively regulates
      source: UniProt:Q5L478
      target: GO:0004197
    - key: positively regulates
      source: UniProt:Q5L478
      target: GO:0004252
    - key: positively correlated with
      source: GO:0004197
      target: MESH:D014779
    - key: positively correlated with
      source: GO:0004252
      target: MESH:D014779
    - key: positively correlated with
      source: MESH:D014779
      target: MESH:D019065
    - key: in taxon
      source: GO:0039694
      target: NCBITaxon:11103
    - key: in taxon
      source: MESH:D019065
      target: NCBITaxon:11103
    - key: causes
      source: NCBITaxon:11103
      target: MESH:D019698
  multigraph: true
  nodes:
    - id: MESH:C586094
      label: Drug
      name: ABT-267
    - id: UniProt:Q5L478
      label: Protein
      name: Nonstructural protein 5A
    - id: GO:0003968
      label: MolecularActivity
      name: RNA-directed 5'-3' RNA polymerase activity
    - id: GO:0039694
      label: BiologicalProcess
      name: viral RNA genome replication
    - id: MESH:C000618292
      label: Protein
      name: PI4KIIIalpha protein, human
    - id: MESH:C037178
      label: ChemicalSubstance
      name: phosphatidylinositol 4-phosphate
    - id: MESH:D002784
      label: ChemicalSubstance
      name: Cholesterol
    - id: MESH:D000086969
      label: CellularComponent
      name: Viral Replication Compartments
    - id: GO:0004197
      label: MolecularActivity
      name: cysteine-type endopeptidase activity
    - id: GO:0004252
      label: MolecularActivity
      name: serine-type endopeptidase activity
    - id: MESH:D014779
      label: BiologicalProcess
      name: Virus Replication
    - id: MESH:D019065
      label: BiologicalProcess
      name: Virus Assembly
    - id: NCBITaxon:11103
      label: OrganismTaxon
      name: Hepacivirus C
    - id: MESH:D019698
      label: Disease
      name: Chronic hepatitis C
  reference: https://go.drugbank.com/drugs/DB09296#mechanism-of-action https://en.wikipedia.org/wiki/Discovery_and_development_of_NS5A_inhibitors#Mechanism_of_action https://en.wikipedia.org/wiki/Discovery_and_development_of_NS5A_inhibitors#Function https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246218/ https://www.ncbi.nlm.nih.gov/books/NBK1623/
  comments: ABT-267 is also known as ombitasvir (see Other names at https://en.wikipedia.org/wiki/Ombitasvir).
- directed: true
  graph:
    disease: Hypoalphalipoproteinemia
    disease_mesh: MESH:D052456
    drug: Inositol Niacinate
    drug_mesh: MESH:C005193
    drugbank: DB:DB08949
  links:
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:P49019
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:Q8TDS4
    - key: part of
      source: UniProt:P49019
      target: REACT:R-HSA-418594
    - key: part of
      source: UniProt:Q8TDS4
      target: REACT:R-HSA-418594
    - key: negatively regulates
      source: REACT:R-HSA-418594
      target: GO:0016042
    - key: decreases abundance of
      source: GO:0016042
      target: MESH:D014280
    - key: negatively correlated with
      source: MESH:D014280
      target: MESH:D008075
    - key: negatively correlated with
      source: MESH:D008075
      target: MESH:D052456
  multigraph: true
  nodes:
    - id: MESH:C005193
      label: Drug
      name: Inositol Niacinate
    - id: UniProt:P49019
      label: Protein
      name: Hydroxycarboxylic acid receptor 3
    - id: UniProt:Q8TDS4
      label: Protein
      name: Hydroxycarboxylic acid receptor 2
    - id: REACT:R-HSA-418594
      label: Pathway
      name: G alpha (i) signalling events
    - id: GO:0016042
      label: BiologicalProcess
      name: lipid catabolic process
    - id: MESH:D014280
      label: ChemicalSubstance
      name: Triglycerides
    - id: MESH:D008075
      label: ChemicalSubstance
      name: Lipoproteins, HDL
    - id: MESH:D052456
      label: Disease
      name: Hypoalphalipoproteinemia
  reference: https://go.drugbank.com/drugs/DB08949#mechanism-of-action https://pubmed.ncbi.nlm.nih.gov/15083592/ https://www.sciencedirect.com/science/article/pii/B978032329738700037X https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441126/ https://en.wikipedia.org/wiki/Triglyceride#Role_in_disease
  comments: Other commonly used names for this drug are inositol nicotinate (CHEBI:50134), myo-inositol hexanicotinate (CHEBI:31699) and inositol hexanicotinate (CHEBI:33064)(https://en.wikipedia.org/wiki/Inositol_nicotinate). This drug is made of niacin (vitamin B3, MESH:D009525) and inositol (MESH:D007294. Note the original drug to curate for this disease was inositol but there is no evidence for it to be used as treatment unless it's bound to nicotinic acid to form inositol hexanicotinate).
- directed: true
  graph:
    disease: Hyperlipidemia, Familial Combined
    disease_mesh: MESH:D006950
    drug: Inositol Niacinate
    drug_mesh: MESH:C005193
    drugbank: DB:DB08949
  links:
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:P49019
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:Q8TDS4
    - key: part of
      source: UniProt:P49019
      target: REACT:R-HSA-418594
    - key: part of
      source: UniProt:Q8TDS4
      target: REACT:R-HSA-418594
    - key: negatively regulates
      source: REACT:R-HSA-418594
      target: GO:0016042
    - key: decreases abundance of
      source: GO:0016042
      target: MESH:D014280
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:C032607
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:D008078
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:D008077
    - key: positively correlated with
      source: MESH:C032607
      target: MESH:D006950
    - key: positively correlated with
      source: MESH:D008078
      target: MESH:D006950
    - key: positively correlated with
      source: MESH:D008077
      target: MESH:D006950
  multigraph: true
  nodes:
    - id: MESH:C005193
      label: Drug
      name: Inositol Niacinate
    - id: UniProt:P49019
      label: Protein
      name: Hydroxycarboxylic acid receptor 3
    - id: UniProt:Q8TDS4
      label: Protein
      name: Hydroxycarboxylic acid receptor 2
    - id: REACT:R-HSA-418594
      label: Pathway
      name: G alpha (i) signalling events
    - id: GO:0016042
      label: BiologicalProcess
      name: lipid catabolic process
    - id: MESH:D014280
      label: ChemicalSubstance
      name: Triglycerides
    - id: MESH:C032607
      label: ChemicalSubstance
      name: low density lipoprotein triglyceride
    - id: MESH:D008078
      label: ChemicalSubstance
      name: Cholesterol, LDL
    - id: MESH:D008077
      label: ChemicalSubstance
      name: Lipoproteins, LDL
    - id: MESH:D006950
      label: Disease
      name: Hyperlipidemia, Familial Combined
  reference: https://go.drugbank.com/drugs/DB08949#mechanism-of-action https://en.wikipedia.org/wiki/Triglyceride#Role_in_disease https://pubmed.ncbi.nlm.nih.gov/15083592/ https://www.sciencedirect.com/science/article/pii/B978032329738700037X https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441126/
  comments: This disease was named Mixed hyperlipidemia in the original file for curation but it's known as Hyperlipidemia, Familial Combined in MESH. Note there does not seem to be any evidence supporting this drug indication (e.g. https://en.wikipedia.org/wiki/Combined_hyperlipidemia#Treatment), so this path is hypothetic and based on the disease phenotype (i.e increased LDL and triglyceride concentrations). Other commonly used names for this drug are inositol nicotinate (CHEBI:50134), myo inositol hexanicotinate (CHEBI:31699) and inositol hexanicotinate (CHEBI:33064)(https://en.wikipedia.org/wiki/Inositol_nicotinate). This drug is made of niacin (vitamin B3, MESH:D009525) and inositol (MESH:D007294. Note the original drug to curate for this disease was inositol but there is no evidence for it to be used as treatment unless it's bound to nicotinic acid to form inositol hexanicotinate.
- directed: true
  graph:
    disease: Hypertriglyceridemia
    disease_mesh: MESH:D015228
    drug: Inositol Niacinate
    drug_mesh: MESH:C005193
    drugbank: DB:DB08949
  links:
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:P49019
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:Q8TDS4
    - key: part of
      source: UniProt:P49019
      target: REACT:R-HSA-418594
    - key: part of
      source: UniProt:Q8TDS4
      target: REACT:R-HSA-418594
    - key: negatively regulates
      source: REACT:R-HSA-418594
      target: GO:0016042
    - key: decreases abundance of
      source: GO:0016042
      target: MESH:D014280
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:D015228
  multigraph: true
  nodes:
    - id: MESH:C005193
      label: Drug
      name: Inositol Niacinate
    - id: UniProt:P49019
      label: Protein
      name: Hydroxycarboxylic acid receptor 3
    - id: UniProt:Q8TDS4
      label: Protein
      name: Hydroxycarboxylic acid receptor 2
    - id: REACT:R-HSA-418594
      label: Pathway
      name: G alpha (i) signalling events
    - id: GO:0016042
      label: BiologicalProcess
      name: lipid catabolic process
    - id: MESH:D014280
      label: ChemicalSubstance
      name: Triglycerides
    - id: MESH:D015228
      label: Disease
      name: Hypertriglyceridemia
  reference: https://go.drugbank.com/drugs/DB08949#mechanism-of-action https://en.wikipedia.org/wiki/Hypertriglyceridemia#Treatment https://en.wikipedia.org/wiki/Triglyceride#Role_in_disease https://pubmed.ncbi.nlm.nih.gov/15083592/ https://www.sciencedirect.com/science/article/pii/B978032329738700037X https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441126/
  comments: Other commonly used names for this drug are inositol nicotinate (CHEBI:50134), myo-inositol hexanicotinate (CHEBI:31699) and inositol hexanicotinate (CHEBI:33064)(https://en.wikipedia.org/wiki/Inositol_nicotinate). This drug is made of niacin (vitamin B3, MESH:D009525) and inositol (MESH:D007294. Note the original drug to curate for this disease was inositol but there is no evidence for it to be used as treatment unless it's bound to nicotinic acid to form inositol hexanicotinate.
- directed: true
  graph:
    disease: Hypercholesterolemia
    disease_mesh: MESH:D006937
    drug: Inositol Niacinate
    drug_mesh: MESH:C005193
    drugbank: DB:DB08949
  links:
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:P49019
    - key: increases activity of
      source: MESH:C005193
      target: UniProt:Q8TDS4
    - key: part of
      source: UniProt:P49019
      target: REACT:R-HSA-418594
    - key: part of
      source: UniProt:Q8TDS4
      target: REACT:R-HSA-418594
    - key: negatively regulates
      source: REACT:R-HSA-418594
      target: GO:0016042
    - key: decreases abundance of
      source: GO:0016042
      target: MESH:D014280
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:C032607
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:D008078
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:D008077
    - key: positively correlated with
      source: MESH:C032607
      target: MESH:D006937
    - key: positively correlated with
      source: MESH:D008078
      target: MESH:D006937
    - key: positively correlated with
      source: MESH:D008077
      target: MESH:D006937
  multigraph: true
  nodes:
    - id: MESH:C005193
      label: Drug
      name: Inositol Niacinate
    - id: UniProt:P49019
      label: Protein
      name: Hydroxycarboxylic acid receptor 3
    - id: UniProt:Q8TDS4
      label: Protein
      name: Hydroxycarboxylic acid receptor 2
    - id: REACT:R-HSA-418594
      label: Pathway
      name: G alpha (i) signalling events
    - id: GO:0016042
      label: BiologicalProcess
      name: lipid catabolic process
    - id: MESH:D014280
      label: ChemicalSubstance
      name: Triglycerides
    - id: MESH:D008077
      label: ChemicalSubstance
      name: Lipoproteins, LDL
    - id: MESH:C032607
      label: ChemicalSubstance
      name: low density lipoprotein triglyceride
    - id: MESH:D008078
      label: ChemicalSubstance
      name: Cholesterol, LDL
    - id: MESH:D006937
      label: Disease
      name: Hypercholesterolemia
  reference: https://go.drugbank.com/drugs/DB08949#mechanism-of-action https://en.wikipedia.org/wiki/Hypercholesterolemia#Medication https://pubmed.ncbi.nlm.nih.gov/15083592/ https://www.sciencedirect.com/science/article/pii/B978032329738700037X https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441126/
  comments: Other commonly used names for this drug are inositol nicotinate (CHEBI:50134), myo-inositol hexanicotinate (CHEBI:31699) and inositol hexanicotinate (CHEBI:33064)(https://en.wikipedia.org/wiki/Inositol_nicotinate). This drug is made of niacin (vitamin B3, MESH:D009525) and inositol (MESH:D007294. Note the original drug to curate for this disease was inositol but there is no evidence for it to be used as treatment unless it's bound to nicotinic acid to form inositol hexanicotinate.
- directed: true
  graph:
    disease: Leukemia, Lymphocytic, Chronic, B-Cell
    disease_mesh: MESH:D015451
    drug: venetoclax
    drug_mesh: MESH:C579720
    drugbank: DB:DB11581
  links:
    - key: negatively regulates
      source: MESH:C579720
      target: UniProt:P10415
    - key: negatively regulates
      source: UniProt:P10415
      target: GO:0097190
    - key: negatively correlated with
      source: GO:0097190
      target: MESH:D015451
  multigraph: true
  nodes:
    - id: MESH:C579720
      label: Drug
      name: venetoclax
    - id: UniProt:P10415
      label: Protein
      name: Apoptosis regulator Bcl-2
    - id: GO:0097190
      label: BiologicalProcess
      name: apoptotic signaling pathway
    - id: MESH:D015451
      label: Disease
      name: Leukemia, Lymphocytic, Chronic, B-Cell
  reference: https://go.drugbank.com/drugs/DB11581#mechanism-of-action https://en.wikipedia.org/wiki/Bcl-2#Venetoclax_(ABT-199)
  comments: MESH:D015451 can also be denoted as Chronic lymphoid leukemia.
- directed: true
  graph:
    disease: Obesity
    disease_mesh: MESH:D009765
    drug: dexfenfluramine
    drug_mesh: MESH:D020372
    drugbank: DB:DB01191
  links:
    - key: negatively regulates
      source: MESH:D020372
      target: UniProt:P31645
    - key: positively regulates
      source: UniProt:P31645
      target: GO:0051610
    - key: positively correlated with
      source: GO:0051610
      target: MESH:D001066
    - key: positively correlated with
      source: MESH:D001066
      target: MESH:D009765
  multigraph: true
  nodes:
    - id: MESH:D020372
      label: Drug
      name: dexfenfluramine
    - id: UniProt:P31645
      label: Protein
      name: Sodium-dependent serotonin transporter
    - id: GO:0051610
      label: BiologicalProcess
      name: serotonin uptake
    - id: MESH:D001066
      label: PhenotypicFeature
      name: Appetite
    - id: MESH:D009765
      label: Disease
      name: Obesity
  reference: https://go.drugbank.com/drugs/DB01191#mechanism-of-action https://en.wikipedia.org/wiki/Dexfenfluramine
  comments: FDA has withdrawn the approval for marketing this drug as per its cardiovascular side-effects.
- directed: true
  graph:
    disease: Obesity
    disease_mesh: MESH:D009765
    drug: dexfenfluramine
    drug_mesh: MESH:D020372
    drugbank: DB:DB01191
  links:
    - key: positively regulates
      source: MESH:D020372
      target: UniProt:P28335
    - key: participates in
      source: UniProt:P28335
      target: REACT:R-HSA-416476
    - key: positively regulates
      source: REACT:R-HSA-416476
      target: GO:0007631
    - key: positively regulates
      source: REACT:R-HSA-416476
      target: GO:0032098
    - key: positively correlated with
      source: GO:0007631
      target: MESH:D009765
    - key: negatively correlated with
      source: GO:0032098
      target: MESH:D009765
  multigraph: true
  nodes:
    - id: MESH:D020372
      label: Drug
      name: dexfenfluramine
    - id: UniProt:P28335
      label: Protein
      name: 5-hydroxytryptamine receptor 2C
    - id: REACT:R-HSA-416476
      label: BiologicalProcess
      name: G alpha (q) signalling events
    - id: GO:0007631
      label: BiologicalProcess
      name: feeding behavior
    - id: GO:0032098
      label: BiologicalProcess
      name: regulation of appetite
    - id: MESH:D009765
      label: Disease
      name: Obesity
  reference: https://go.drugbank.com/drugs/DB01191#mechanism-of-action https://en.wikipedia.org/wiki/5-HT2C_receptor_agonist#Obesity https://en.wikipedia.org/wiki/5-HT2C_receptor_agonist#Mechanism_of_action
  comments: FDA has withdrawn the approval for marketing this drug as per its cardiovascular side-effects.
- directed: true
  graph:
    disease: Rheumatoid arthritis
    disease_mesh: MESH:D001172
    drug: ketoprofen
    drug_mesh: MESH:D007660
    drugbank: DB:DB01009
  links:
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P23219
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0005059
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001386
    - key: positively correlated with
      source: HP:0001386
      target: MESH:D001172
    - key: positively correlated with
      source: HP:0005059
      target: MESH:D001172
  multigraph: true
  nodes:
    - id: MESH:D007660
      label: Drug
      name: ketoprofen
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0005059
      label: PhenotypicFeature
      name: Joint pain/Joint inflammation
    - id: HP:0001386
      label: PhenotypicFeature
      name: Joint swelling
    - id: MESH:D001172
      label: Disease
      name: Rheumatoid arthritis
  reference: https://go.drugbank.com/drugs/DB01009#mechanism-of-action https://en.wikipedia.org/wiki/Ketoprofen#Mechanism https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Anti-inflammatory_and_analgesic_agents
- directed: true
  graph:
    disease: Rheumatoid arthritis
    disease_mesh: MESH:D001172
    drug: ketoprofen
    drug_mesh: MESH:D007660
    drugbank: DB:DB01009
  links:
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P25024
    - key: positively regulates
      source: UniProt:P25024
      target: GO:0030593
    - key: positively regulates
      source: UniProt:P25024
      target: GO:0002407
    - key: positively correlated with
      source: GO:0030593
      target: MESH:D020556
    - key: positively correlated with
      source: MESH:D020556
      target: HP:0005059
    - key: positively correlated with
      source: MESH:D020556
      target: HP:0001386
    - key: positively correlated with
      source: GO:0002407
      target: GO:0006954
    - key: positively correlated with
      source: GO:0006954
      target: MESH:D001172
    - key: positively correlated with
      source: HP:0005059
      target: MESH:D001172
    - key: positively correlated with
      source: HP:0001386
      target: MESH:D001172
  multigraph: true
  nodes:
    - id: MESH:D007660
      label: Drug
      name: ketoprofen
    - id: UniProt:P25024
      label: Protein
      name: C-X-C chemokine receptor type 1
    - id: GO:0030593
      label: BiologicalProcess
      name: neutrophil chemotaxis
    - id: GO:0002407
      label: BiologicalProcess
      name: dendritic cell chemotaxis
    - id: HP:0005059
      label: PhenotypicFeature
      name: Joint pain/Joint inflammation
    - id: HP:0001386
      label: PhenotypicFeature
      name: Joint swelling
    - id: MESH:D020556
      label: BiologicalProcess
      name: Neutrophil Infiltration
    - id: GO:0006954
      label: BiologicalProcess
      name: inflammatory response
    - id: MESH:D001172
      label: Disease
      name: Rheumatoid arthritis
  reference: https://go.drugbank.com/drugs/DB01009#BE0003552 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943798/
- directed: true
  graph:
    disease: Pain
    disease_mesh: MESH:D010146
    drug: ketoprofen
    drug_mesh: MESH:D007660
    drugbank: DB:DB01009
  links:
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P23219
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: MESH:D010146
  multigraph: true
  nodes:
    - id: MESH:D007660
      label: Drug
      name: ketoprofen
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: MESH:D010146
      label: Disease
      name: Pain
  reference: https://go.drugbank.com/drugs/DB01009 https://en.wikipedia.org/wiki/Analgesic#COX-2_inhibitors
- directed: true
  graph:
    disease: Dysmenorrhea
    disease_mesh: MESH:D004412
    drug: ketoprofen
    drug_mesh: MESH:D007660
    drugbank: DB:DB01009
  links:
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P23219
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively regulates
      source: MESH:D011453
      target: MESH:D014590
    - key: positively correlated with
      source: MESH:D014590
      target: MESH:D004412
  multigraph: true
  nodes:
    - id: MESH:D007660
      label: Drug
      name: ketoprofen
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: MESH:D014590
      label: PhenotypicFeature
      name: Uterine Contraction
    - id: MESH:D004412
      label: Disease
      name: Dysmenorrhea
  reference: https://go.drugbank.com/drugs/DB01009 https://www.aafp.org/afp/1999/0801/p489.html
- directed: true
  graph:
    disease: Osteoarthritis
    disease_mesh: MESH:D010003
    drug: ketoprofen
    drug_mesh: MESH:D007660
    drugbank: DB:DB01009
  links:
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P23219
    - key: negatively regulates
      source: MESH:D007660
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0002829
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001386
    - key: positively correlated with
      source: HP:0001386
      target: MESH:D010003
    - key: positively correlated with
      source: HP:0002829
      target: MESH:D010003
  multigraph: true
  nodes:
    - id: MESH:D007660
      label: Drug
      name: ketoprofen
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0002829
      label: PhenotypicFeature
      name: Joint pain
    - id: HP:0001386
      label: PhenotypicFeature
      name: Joint swelling
    - id: MESH:D010003
      label: Disease
      name: Osteoarthritis
  reference: https://go.drugbank.com/drugs/DB01009
  comments: In contrast to rheumatoid arthritis, in osteoarthritis the joints do not become hot or red.  (https://en.wikipedia.org/wiki/Osteoarthritis#cite_note-NIH2015-1)
- directed: true
  graph:
    disease: Pellagra
    disease_mesh: MESH:D010383
    drug: Inositol Niacinate
    drug_mesh: MESH:C005193
    drugbank: DB:DB08949
  links:
    - key: increases abundance of
      source: MESH:C005193
      target: CHEBI:15940
    - key: increases abundance of
      source: CHEBI:15940
      target: CHEBI:17154
    - key: negatively correlated with
      source: CHEBI:17154
      target: HP:0100497
    - key: positively correlated with
      source: HP:0100497
      target: MESH:D010383
  multigraph: true
  nodes:
    - id: MESH:C005193
      label: Drug
      name: Inositol Niacinate
    - id: CHEBI:15940
      label: ChemicalSubstance
      name: nicotinic acid
    - id: CHEBI:17154
      label: ChemicalSubstance
      name: nicotinamide
    - id: HP:0100497
      label: PhenotypicFeature
      name: Vitamin B3 deficiency
    - id: MESH:D010383
      label: Disease
      name: Pellagra
  reference: https://go.drugbank.com/drugs/DB08949#mechanism-of-action https://pubchem.ncbi.nlm.nih.gov/compound/3720#section=Drug-and-Medication-Information https://en.wikipedia.org/wiki/Pellagra#Treatment https://en.wikipedia.org/wiki/Nicotinamide https://en.wikipedia.org/wiki/Nicotinamide#Niacin_deficiency https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1250
  comments: Other commonly used names for this drug are inositol nicotinate (CHEBI:50134), myo-inositol hexanicotinate (CHEBI:31699) and inositol hexanicotinate (CHEBI:33064)(https://en.wikipedia.org/wiki/Inositol_nicotinate). This drug is made of niacin (vitamin B3, MESH:D009525) and inositol (MESH:D007294. Note the original drug to curate for this disease was inositol but there is no evidence for it to be used as treatment unless it's bound to nicotinic acid to form inositol hexanicotinate.??
- directed: true
  graph:
    disease: Acne vulgaris
    disease_mesh: MESH:D000152
    drug: Adapalene
    drug_mesh: MESH:D000068816
    drugbank: DB:DB00257
  links:
    - key: positively regulates
      source: MESH:D000068816
      target: MESH:D018168
    - key: negatively regulates
      source: MESH:D018168
      target: GO:0031424
    - key: increases abundance of
      source: GO:0031424
      target: HP:0025249
    - key: positively correlated with
      source: HP:0025249
      target: MESH:D000152
  multigraph: true
  nodes:
    - id: MESH:D000068816
      label: Drug
      name: Adapalene
    - id: MESH:D018168
      label: GeneFamily
      name: Receptors, Retinoic Acid
    - id: GO:0031424
      label: BiologicalProcess
      name: keratinization
    - id: HP:0025249
      label: PhenotypicFeature
      name: Comedo
    - id: MESH:D000152
      label: Disease
      name: Acne vulgaris
  reference: https://go.drugbank.com/drugs/DB00210#mechanism-of-action https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374937/ https://en.wikipedia.org/wiki/Adapalene#Pharmacodynamics https://pubmed.ncbi.nlm.nih.gov/19929446/
- directed: true
  graph:
    disease: Acne vulgaris
    disease_mesh: MESH:D000152
    drug: Adapalene
    drug_mesh: MESH:D000068816
    drugbank: DB:DB00257
  links:
    - key: negatively regulates
      source: MESH:D000068816
      target: UniProt:O60603
    - key: positively regulates
      source: UniProt:O60603
      target: UniProt:P05412
    - key: positively correlated with
      source: UniProt:P05412
      target: GO:0006954
    - key: caused by
      source: GO:0006954
      target: NCBITaxon:1747
    - key: positively correlated with
      source: NCBITaxon:1747
      target: MESH:D000152
  multigraph: true
  nodes:
    - id: MESH:D000068816
      label: Drug
      name: Adapalene
    - id: UniProt:O60603
      label: Protein
      name: Toll-like receptor 2
    - id: UniProt:P05412
      label: Protein
      name: Transcription factor AP-1
    - id: GO:0006954
      label: BiologicalProcess
      name: inflammatory response
    - id: GO:0006954
      label: BiologicalProcess
      name: inflammatory response
    - id: NCBITaxon:1747
      label: OrganismTaxon
      name: Cutibacterium acnes
    - id: MESH:D000152
      label: Disease
      name: Acne vulgaris
  reference: https://go.drugbank.com/drugs/DB00210#mechanism-of-action https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374937/ https://en.wikipedia.org/wiki/Adapalene#Pharmacodynamics https://pubmed.ncbi.nlm.nih.gov/19929446/

